Health
Sortilin may hold the key to developing more effective treatment for pancreatic cancer – News-Medical.Net
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Reviewed by Emily Henderson, B.Sc.Aug 20 2020
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
There is currently no good therapy for pancreatic cancer. What we …
-
Noosa News24 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General24 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News22 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Business17 hours agoBroker names 2 small cap ASX shares to buy for big returns